Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
4.830
+0.030 (0.63%)
At close: May 14, 2026, 4:00 PM EDT
4.830
0.00 (0.00%)
After-hours: May 14, 2026, 6:03 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $458.27 million as of May 14, 2026. Its market cap has increased by 335.22% in one year.
Market Cap
458.27M
Enterprise Value
235.53M
1-Year Change
335.22%
Ranking
Category
Stock Price
$4.83
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $458.27M, an increase of 173.88%. That is a compound annual growth rate of 23.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 458.27M | 34.50% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 471.07M |
| Fulcrum Therapeutics | 468.43M |
| Prelude Therapeutics | 466.68M |
| Sagimet Biosciences | 463.14M |
| Lexeo Therapeutics | 459.35M |
| Autolus Therapeutics | 456.44M |
| Lyell Immunopharma | 446.12M |
| ADC Therapeutics | 438.81M |